Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Angiogenesis and Inflammation in Biological Barriers (Deadline: 31 January 2021)
- Pancreatic Ductal Adenocarcinoma: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 January 2021)
- Skin Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 28 February 2021)
- Immunonutrition: Biomedical Basis for Disease Management (Deadline: 28 February 2021)
- Extracellular Vesicles in Inflammation (Deadline: 31 March 2021)
- Poxviruses: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 March 2021)
- Immune Checkpoints and Autoimmunity (Deadline: 30 April 2021)
- Immunology of Hearing (Deadline: 30 April 2021)
- Immunometabolites: Small Molecules as a Novel Therapy in Immune Response (Deadline: 30 April 2021)
- Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer (Deadline: 30 April 2021)
- Epigenetic Control of the Immune System in Health and Disease (Deadline: 31 May 2021)
- Immunoglobulins in Inflammation 2.0 (Deadline: 31 May 2021)
- Cellular and Immunotherapy for Acute Lymphoblastic Leukemia (Deadline: 31 May 2021)
- Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches 2.0 (Deadline: 31 May 2021)
- Advanced Research in Molecular Imaging of Immunity and Inflammation (Deadline: 30 June 2021)
- Molecular Targets for Biological Therapies of Severe Asthma (Deadline: 15 July 2021)
- Mechanism and Modulation in Sepsis (Deadline: 15 July 2021)
- Mucocutaneous Manifestations of HIV after 40 Years from the First Case (Deadline: 31 July 2021)
